Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study

Geriatrics and Gerontology International

Volumn 15, Issue 4, 2015, Pages 449-456

  Mirbolouk, Mohammadhassan ^a   Asgari, Samaneh ^a   Sheikholeslami, Farhad ^a   Mirbolouk, Fardin ^c   Azizi, Fereidoun ^b   Hadaegh, Farzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aged; Cardiovascular disease; Metabolic syndrome X; Obesity

Indexed keywords

GLUCOSE; LIPID; GLUCOSE BLOOD LEVEL;

AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; IRANIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RISK; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPLICATION; GLUCOSE BLOOD LEVEL; INCIDENCE; IRAN; METABOLISM; MORTALITY; RISK FACTOR;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; IRAN; LIPIDS; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; RISK FACTORS;

EID: 84926157731     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12295     Document Type: Article

References (31)

1. Ayatollahi SM, Ghoreshizadeh Z. Prevalence of obesity and overweight among adults in Iran. Obes Rev 2010; 11: 335-337.
2. Curbing the obesity epidemic. Lancet 2006; 367: 1549.
3. Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav 2005; 86: 599-602.
4. Romero-Corral A, Montori VM, Somers VK etal. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666-678.
5. Donini LM, Savina C, Gennaro E etal. A systematic review of the literature concerning the relationship between obesity and mortality in the elderly. J Nutr Health Aging 2012; 16: 89-98.
6. Perotto M, Panero F, Gruden G etal. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. Acta Diabetol 2013; 50: 563-568.
7. Goel K, Lopez-Jimenez F, De Schutter A, Coutinho T, Lavie CJ. Obesity paradox in different populations: evidence and controversies. Future Cardiol 2014; 10: 81-91.
8. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230-236.
9. Calori G, Lattuada G, Piemonti L etal. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210-215.
10. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488.
11. Ortega FB, Lee DC, Katzmarzyk PT etal. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389-397.
12. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 2012; 20: 651-659.
13. Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol 2011; 107: 412-416.
14. Durward CM, Hartman TJ, Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes 2012; 2012: 460321.
15. Barusch AS. The aging tsunami: time for a new metaphor? J Gerontol Soc Work 2013; 56: 181-184.
16. Gressani D, Larbi H. Islamic Republic of Iran - health sector review [monograph on the Internet]. World Bank Washington, 2008. [Cited 14 Aug 2013.] Available from URL: http://hdl.handle.net/10986/7960.
17. Cho HJ, Choi KM, Choi HY etal. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf) 2013; 79: 364-370.
18. Azizi F, Ghanbarian A, Momenan AA etal. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10: 5.
19. Global database on body mass index. World Health Organization, 2006.
20. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WP, Azizi F. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond) 2009; 33: 1437-1445.
21. Alberti KG, Eckel RH, Grundy SM etal. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
22. Hadaegh F, Mohebi R, Cheraghi L etal. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the Tehran lipid and glucose study. Stroke 2012; 43: 1669-1671.
23. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1-7.
24. Janssen I, Bacon E. Effect of current and midlife obesity status on mortality risk in the elderly. Obesity (Silver Spring) 2008; 16: 2504-2509.
25. Hadaegh FZA, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F. Prevalence of metabolic syndrome by the adult treatment panel III, international diabetes federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore 2009; 38: 142-149.
26. Kyrou I, Tsigos C. Obesity in the elderly diabetic patient: is weight loss beneficial? No. Diabetes Care 2009; 32 (Suppl 2): S403-S409.
27. Sorkin JD, Muller DC, Andres R. Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging. Am J Epidemiol 1999; 150: 969-977.
28. Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Ghanbarian A, Azizi F. Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality. Cardiovasc Diabetol 2012; 11: 69.
29. Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study. J Endocrinol Invest 2012; 35: 14-20.
30. Tobias DK, Pan A, Jackson CL etal. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 2014; 370: 233-244.
31. Motlagh B, O'Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 2009; 16: 268-280.